* Caring For Children * Sampling Project * Latest News












 
2007/8/29 EU patent [lead compound for cancer suppression, diminish infection, and health improvement] approved

Patent Filing Date: 2001/04/04
Registration Number: 01303197.6
Approval Sate: 2007/08/02

Abstract
This invention applies fermented soybean extract for prevention/ therapy of certain cancer, it also inhibits the function of LOX-5, LOX-12, LOX-15; It is also beneficial for purpose of health improvement.

Summary
The invented fermented soybean extract can lead to apoptosis of certain cancer cells, and to lower cancer cell spreading and angiogenesis in order to suppress cancer cells. The other noticeable functions include suppressing LOX enzymes, having antioxidant effect, suppressing free radicals, and also beneficial for human health.

Patent filing area

  1. It is an active component apply for prevention or therapy in breast cancer, lung cancer, hepatoma, kidney cancer, cervical cancer, GIT cancer. The main ingredient derived from soybean extract through symbiosis process with at least one strain of lactobacillus and one strain of saccharomyces. This active ingredient can inhibit lipooxygenase.
  2. as mentioned in the above, lipooxygenase contain LOX-5, LOX-12 or LOX-15
  3. as mentioned in sentence 1, the lactobacillus is of lactobacillus strain
  4. as mentioned in sentence 1, saccharomyces must be of Saccharomyces strain
  5. it include ingredients and processing methods with purpose indicated
  6. as mentioned sentence 5, it indicates the application of LOX-5, LOX12, LOX-15
  7. as mentioned sentence 5, it indicates the application of lactobacillus
  8. as mentioned sentence 5, it indicates the application of Saccharomyces


 

 
|HOME|
Copyright © MicroBio Co., Ltd. All Rights Reserved.